Daily Newsletter

15 July 2024

Daily Newsletter

15 July 2024

Bedal secures $11m to strengthen FlexGRIP catheter device growth

The proceeds will be used to boost the company's operations and commercial efforts, particularly in the US market.

Archana Rani July 15 2024

Bedal International has announced the successful closure of an $11m funding round aimed at bolstering the global growth of its FlexGRIP catheter securement devices.

The investment is set to enhance the company's operations and commercial efforts, particularly in the US market.

The funding round was spearheaded by Belgian venture capitalist fund White Fund and Belgium's Sovereign Wealth Fund, SFPIM.

It also saw participation from US-based medtech investors and Bedal's existing backers, F3Finance and LRM. The Bedal management team also participated in the round.

White Fund official Eric Brandt said: “White Fund and SFPIM are excited to support Bedal’s mission to improve patient care through its innovative devices.”

SFPIM CIO Céline Vaessen said: “We believe in Bedal’s potential to become the golden standard for catheter care. We are proud to be part of their promising growth journey and are committed to supporting their product development engine with the ambition of making a profound impact on the lives of patients and caregivers.”

Designed to safely secure catheters, FlexGRIP devices are currently utilised in more than 34 countries. They have been instrumental in reducing complications and enhancing patient outcomes.

Bedal has also secured global agreements with several catheter companies.

Bedal International CEO Alexander Van Damme said: "Since we founded Bedal, it has already been an incredible journey from launching the devices to growing into a global footprint.

“This new funding marks the beginning of a next chapter for us, focused on setting a new standard in the market.”

Bedal’s FlexGRIP products are designed to enhance catheter stabilisation while reducing the risk of dislodgement, infection, and kinking.

United States (US) Telehealth Market Overview

Per GlobalData, the US telehealth market was valued at 101.8 million in 2023. Hospitals and clinics are key distribution channels in the US telehealth market. In 2023, hospitals accounted for the largest distribution channel share of the telehealth market in the US while the telehealth software and services segment was the highest revenue contributor.

United States (US) Telehealth Market Overview

Per GlobalData, the US telehealth market was valued at 101.8 million in 2023. Hospitals and clinics are key distribution channels in the US telehealth market. In 2023, hospitals accounted for the largest distribution channel share of the telehealth market in the US while the telehealth software and services segment was the highest revenue contributor.

United States (US) Telehealth Market Overview

Per GlobalData, the US telehealth market was valued at 101.8 million in 2023. Hospitals and clinics are key distribution channels in the US telehealth market. In 2023, hospitals accounted for the largest distribution channel share of the telehealth market in the US while the telehealth software and services segment was the highest revenue contributor.

Newsletters by sectors

close

Sign up to the newsletter: In Brief

Visit our Privacy Policy for more information about our services, how we may use, process and share your personal data, including information of your rights in respect of your personal data and how you can unsubscribe from future marketing communications. Our services are intended for corporate subscribers and you warrant that the email address submitted is your corporate email address.

Thank you for subscribing

View all newsletters from across the GlobalData Media network.

close